A review of irritable bowel syndrome and an update on therapeutic approaches

Expert Opinion on Pharmacotherapy
John T Bassett, Brooks D Cash

Abstract

Irritable bowel syndrome is a common disorder that is associated with a significant impact on both affected individuals and society. While the pathophysiology of irritable bowel syndrome remains unknown, knowledge regarding the normal and abnormal functions of the gut and its complex interactions with the body's nervous systems continue to shed light on the multifactiorial origins of irritable bowel syndrome symptoms. This article provides an overview of the current knowledge on the therapeutic approaches to irritable bowel syndrome. A search of the online bibliographic databases MEDLINE and EMBASE was performed in order to identify all relevant articles published between 1980 and 2008. The search was enhanced with the use of a medical librarian. Bibliographies from potentially relevant articles were manually searched. The therapeutic options for irritable bowel syndrome are rapidly evolving beyond traditional symptom-based therapies, such as fiber, antispasmodics, antidiarrheals and laxatives and are moving towards agents with organ-specific receptor selectivity directed, in many cases, at specific gastrointestinal functions.

References

Feb 10, 1979·British Medical Journal·J A Ritchie, S C Truelove
Sep 2, 1978·British Medical Journal·A P ManningA F Morris
Jul 1, 1990·Journal of Pediatric Gastroenterology and Nutrition·E Barau, C Dupont
Dec 1, 1990·Annals of Internal Medicine·D A DrossmanC M Mitchell
Aug 1, 1990·Gastroenterology·R S Sandler
Mar 1, 1990·Gastroenterology·G BazzocchiW J Snape
Jun 1, 1981·Journal of Clinical Gastroenterology·J G Page, G M Dirnberger
Dec 1, 1995·Gastroenterology·N J TalleyR W Evans
Apr 2, 1994·Lancet·P BytzerO B Schaffalitzky de Muckadell
Aug 24, 1999·Gut·W G ThompsonS A Müller-Lissner
Feb 12, 2000·Progress in Neurobiology·E J HorváthM Palkovits
Jul 19, 2000·Digestion·F AzpirozA Smout
Nov 4, 2000·The American Journal of Medicine·J L JacksonK Kroenke
Jan 11, 2001·The American Journal of Gastroenterology·M PimentelH C Lin
Aug 22, 2001·The American Journal of Gastroenterology·Y K ChanJ E Kellow
Aug 22, 2001·The American Journal of Gastroenterology·A MalcolmM J Cousins
Sep 25, 2001·The American Journal of Gastroenterology·T LemboUNKNOWN Lotronex Investigator Team
Oct 16, 2001·American Journal of Physiology. Cell Physiology·C A HirshmanC W Emala
May 2, 2002·Gastroenterology·Robert S SandlerRobert Rubin
Jun 1, 2002·Behaviour Research and Therapy·L Keefer, E B Blanchard
Jun 11, 2002·Gastroenterology·Vinton S ChadwickIan Wilson
Nov 12, 2002·The American Journal of Gastroenterology·Brooks D CashWilliam D Chey
Nov 28, 2002·Digestive Diseases and Sciences·Olafur S PalssonWilliam E Whitehead
Nov 28, 2002·Gastroenterology·Douglas A DrossmanWilliam E Whitehead
Dec 7, 2002·European Journal of Gastroenterology & Hepatology·Stefan A Müller-Lissner, Olaf Pirk
Jan 31, 2003·Gastroenterology·Francis CreedUNKNOWN North of England IBS Research Group
Mar 13, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·Silvia Delgado-ArosAlan R Zinsmeister
Feb 27, 2004·Alimentary Pharmacology & Therapeutics·C J BijkerkN J de Wit

❮ Previous
Next ❯

Citations

Nov 26, 2015·Scandinavian Journal of Gastroenterology·Chen-Shuan ChungYen-Hsuan Ni
Jan 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Shilan MozaffariMohammad Abdollahi
May 7, 2011·Journal of Clinical Pharmacy and Therapeutics·K E Trinkley, M C Nahata
May 8, 2019·Journal of Speech, Language, and Hearing Research : JSLHR·Joshua M Alexander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Emerging Drugs
Ruben D Acosta, Brooks D Cash
Therapeutic Advances in Gastroenterology
Anita Sainsbury, Alexander C Ford
Current Opinion in Endocrinology, Diabetes, and Obesity
Michael D Gershon
© 2022 Meta ULC. All rights reserved